2018 Regular Session ENROLLED
SENATE BILL NO. 27
BY SENATOR MILLS
1 AN ACT
2 To amend and reenact R.S. 46:153.3(D)(1) and (2), relative to the Medicaid Pharmaceutical
3 and Therapeutics Committee; to provide for committee composition; to provide for
4 committee diversity; to provide for nominating entities; to provide for filling of
5 vacancies; and to provide for related matters.
6 Be it enacted by the Legislature of Louisiana:
7 Section 1. R.S. 46:153.3(D)(1) and (2) are hereby amended and reenacted to read
8 as follows:
9 ยง153.3. Medical vendor reimbursements; allowable restrictions; peer-based
10 prescribing and dispensing practice patterns; Medicaid
11 Pharmaceutical and Therapeutics Committee
12 * * *
13 D.(1) The Medicaid Pharmaceutical and Therapeutics Committee, hereinafter
14 referred to as "the committee", is hereby created within the Louisiana Department
15 of Health. The committee shall be composed of twenty-one fifteen members
16 appointed by the governor and submitted to the Senate for confirmation. The
17 committee shall be representative of the state's geographic and demographic
18 composition, including women and minorities. The governor shall ensure that
19 appointments achieve race, gender, and geographic diversity.
20 (2)(a) Each nominating organization shall certify by affidavit that the practice
21 of each nominee involves either the care of or the supervision of the care of no less
22 than one hundred Medicaid recipients. The committee shall be comprised of the
23 following persons:
24 (a)(i) One physician with expertise in the area of pharmacology representing
25 nominated by the Louisiana State University Health Sciences Center.
26 (b)(ii) One physician with expertise in the area of pharmacology representing
ACT No. 644
Page 1 of 3
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 27 ENROLLED
1 nominated by Tulane University School of Medicine.
2 (c) One practicing physician who is participating in the Title XIX program
3 as a family practitioner recommended by the Louisiana State Medical Society.
4 (d) One practicing physician who is participating in the Title XIX program
5 as an internal medicine specialist recommended by the Louisiana State Medical
6 Society.
7 (e) One practicing physician who is participating in the Title XIX program
8 as a pediatrician recommended by the Louisiana State Medical Society.
9 (f) One practicing physician who is participating in the Title XIX program
10 as a surgeon recommended by the Louisiana State Medical Society.
11 (g) One practicing physician who is participating in the Title XIX program
12 as an obstetrics/gynecologist recommended by the Louisiana State Medical Society.
13 (h) Two practicing physicians who are participating in the Title XIX program
14 recommended by the Louisiana Medical Association.
15 (iii) Four physicians nominated by the Louisiana State Board of Medical
16 Examiners.
17 (i)(iv) One pharmacist representing nominated by the University of
18 Louisiana at Monroe School of Pharmacy.
19 (j)(v) One pharmacist representing nominated by the Xavier University of
20 Louisiana School of Pharmacy.
21 (k)(vi) Two practicing pharmacists who are participating in the Title XIX
22 drug program nominated by the Louisiana Board of Pharmacy. One pharmacist
23 shall be an independent pharmacist recommended by the Louisiana Independent
24 Pharmacies Association and one pharmacist shall be a pharmacist representing a
25 chain pharmacy recommended by the Louisiana Pharmacists Association.
26 (l)(vii) The secretary of the Louisiana Department of Health, or his designee.
27 (m)(viii) The director of the Medicaid program in the Louisiana Department
28 of Health or his designee.
29 (n)(ix) The president of the Senate or the president's designee.
30 (o)(x) The speaker of the House of Representatives or the speaker's designee.
Page 2 of 3
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 27 ENROLLED
1 (p) One practicing physician who is participating in the Title XIX program
2 as a psychiatrist recommended by the Louisiana Psychiatric Medical Association.
3 (q)(xi) A consumer member who shall be a Medicaid recipient.
4 (r) One physician representing the Department of Neurology at Louisiana
5 State University Health Sciences Center.
6 (s) One physician who is a pediatric oncologist representing the Louisiana
7 State University Health Sciences Center.
8 (b) Any committee member who misses two consecutive meetings may
9 be replaced. The department may send notice to the nominating organization
10 upon the second recorded absence. The nominating organization shall have
11 thirty calendar days from issuance of the notice to submit replacement
12 nominations to the office of the governor. If replacement nominations are not
13 received within thirty days, the department shall nominate a replacement.
14 * * *
15 Section 2. Nominating organizations shall submit the names of their nominees to the
16 governor on or before August 1, 2018. If a nominating organization does not submit
17 nominees to the governor by August 1, 2018, the department shall submit nominees to the
18 governor for the respective vacant committee seat on or before September 1, 2018.
19 Appointments shall be made on or before October 1, 2018.
PRESIDENT OF THE SENATE
SPEAKER OF THE HOUSE OF REPRESENTATIVES
GOVERNOR OF THE STATE OF LOUISIANA
APPROVED:
Page 3 of 3
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.